[1]
Sarici, A., Erkurt, M.A., Bahcecioglu, O.F., Tanriverdi, L.H., Berber, I., Kaya, E., Bicim, S., Gok, S., Ozgul, M. and Kuku, I. 2021. Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience. Annals of Medical Research. 28, 11 (Nov. 2021), 2065–2070.